Bahram Valamehr, Chief R&D Officer at FATE THERAPEUTICS INC (FATE), sold 21,834 shares at $5.24 ($114K) on 2023-01-10, disclosed to the SEC on 2023-01-11.
Seasonal sale ($114k) by Chief R&D Officer — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.24 | 10,917 | $57K | 50.0% |
| 2 | $5.24 | 10,917 | $57K | 50.0% |
| Total | $5.24 avg | 21,834 | $114K | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |